Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf Wegovy is injected into muscle rather than the layer of fat beneath the skin, the medicine is absorbed faster than intended, which can make side effects — particularly nausea — feel more intense in the hours that follow. The pen is designed for subcutaneous injection only: into the soft fatty tissue of the abdomen, thigh, or upper arm. That matters because the depth and speed of absorption affect both tolerability and how consistently the medicine works over the week. Semaglutide (Wegovy) is a prescription-only medicine, and the full instructions in your Patient Information Leaflet cover the correct technique in detail; if you have any doubt about what happened or how you're feeling after an injection, contact your prescribing team promptly. Learn more about how Wegovy works before your next dose.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's an unsettling feeling. You pressed the Wegovy pen against your thigh or abdomen, clicked, and the injection felt sharper than usual, or deeper, or simply different from last week. Now you're wondering whether you've done it wrong and what that means. You're not alone, this is one of the questions our prescribers hear regularly, and it deserves a straight answer.
Wegovy's pre-filled pen is designed to deliver semaglutide into the subcutaneous layer: the soft cushion of fatty tissue sitting just below the skin. That layer absorbs the medicine gradually, spreading the dose across the week in a controlled way. Muscle sits beneath that, it has a richer blood supply and absorbs substances noticeably faster. So if the needle reached muscle, the medicine still enters your body, but the timing of absorption shifts. The dose itself isn't lost or doubled; it just moves into your system more quickly than the design intended.
The NHS medicines page for semaglutide confirms that Wegovy is for subcutaneous use, and the Patient Information Leaflet gives specific guidance on needle depth and pinching technique, both are worth revisiting before your next injection.
Faster absorption tends to mean a steeper, shorter spike in the medicine's activity rather than the gentler, sustained curve the subcutaneous route produces. In practice, this often shows up as more pronounced nausea, quicker feelings of fullness, or a stronger wave of fatigue in the first few hours after the injection, effects that usually settle by the following day.
Localised discomfort at the site is also common. Muscle tissue is more sensitive to injected fluid than fat, so you may notice more aching, tenderness, or a harder lump than usual. That typically resolves within a couple of days. If the injection landed in the thigh, it may ache when you walk; in the upper arm, when you lift.
What's less likely: any fundamental change to how much weight you lose over the week, or any lasting damage from a single accidental event. The semaglutide molecule itself is the same regardless of where it lands. The detailed guide on accidentally injecting Wegovy into muscle covers the full picture if you want more reassurance.
Signs that need same-day medical attention: severe pain that worsens rather than settles, significant swelling or redness that spreads, numbness, or feeling unwell beyond mild nausea. That kind of response is unusual but shouldn't be ignored.
A single intramuscular injection is rarely a clinical crisis. Consistency over time is the real concern. If every injection reaches muscle because the technique isn't quite right, the erratic absorption pattern may blunt the medicine's effectiveness across weekly cycles, and side effects stay bumpier than they need to be.
The practical fixes are straightforward. Abdomen injections work best when you pinch a good fold of skin, it's harder to reach muscle through a proper subcutaneous fold. Thigh injections sometimes catch muscle in leaner individuals, especially sitting down; standing and relaxing the leg before injecting helps. Upper arm injections are easiest if someone else does them. The needle length on the Wegovy pen is set for most adults, but if you're very lean your prescriber may have specific guidance.
It's also worth knowing that rotating sites matters even when technique is right. Injecting repeatedly into the same small spot, whether in fat or at the boundary with muscle, builds scar tissue that changes absorption unpredictably. More on what the research says about intramuscular semaglutide injection is available if you want to understand the pharmacokinetics in more depth.
If you're uncertain about your technique and want a clinician to review it, that conversation can happen as part of your ongoing care at our support team, seven days a week.
One accidental intramuscular injection doesn't mean you've harmed your treatment or need to restart. Carry on with your regular weekly schedule: the next dose goes in at the usual time, with fresh technique. The guide for people who've already injected Wegovy into muscle and want to know next steps sets out a clear action plan.
If side effects from this injection felt significantly worse than usual, mention it to your prescribing team before your next dose rather than quietly hoping it improves. There may be a small technique adjustment (pinch depth, angle, or site choice) that makes a real difference to tolerability. That's exactly the kind of thing clinical aftercare is for, and it's included as standard when you're treated through a registered online pharmacy with genuine prescriber support.
For context on the broader picture of Wegovy and what stopping or changing your treatment involves, this page explains what happens if you stop Wegovy mid-course, a different question, but one that often comes up alongside injection worries. And if you've ever wondered whether other injection sites create unexpected effects, the guide on injecting Wegovy into a stretch mark addresses a similarly common concern.
If you're not yet on Wegovy and are working out whether it's the right route for you, start a free consultation with our prescribers, a real clinician reads every assessment the same day, and the conversation covers injection technique alongside eligibility. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines is also worth reading for the full safety picture from the UK regulator.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.